Combination Therapy in Type 2 Diabetes: Which Second Drug, When to Add It and What Each One Costs You
Type 2 diabetes has three separate defects running at once: the liver releasing glucose it does not need to, muscle and fat ignoring insulin, and the pancreas slowly losing the capacity to produce it. A single drug addresses one or two of those. Over years, the third one wins.
That is why needing a second medicine is not a personal failure or evidence of neglect. It is the expected course of the illness, and most people treated with one drug need a second within a few years of diagnosis. Starting a single drug is covered in our guide to monotherapy in type 2 diabetes.
🎯 The target, and why it is not the same for everyone
HbA1c reflects average glucose over roughly the previous three months. The general target is below 7 percent, which is 53 mmol/mol, and it is deliberately adjusted up or down.
| Target | Who |
|---|---|
| 6.5 percent (48 mmol/mol) | Younger, recently diagnosed, no complications, on drugs that do not cause hypoglycaemia |
| 7 percent (53 mmol/mol) | The usual target for most adults |
| 7.5 to 8 percent (58 to 64 mmol/mol) | Older age, limited life expectancy, established complications, a history of severe hypoglycaemia, or living alone where a hypoglycaemic episode would be dangerous |
Pushing an 82-year-old on a sulfonylurea to 6.5 percent causes more harm than the half percent prevents. Knowing your own agreed target is worth more than knowing your last reading.
📊 How much each class actually does
This table is the practical core of the subject, and it is what most articles on combination therapy leave out. Figures are approximate reductions in HbA1c when a class is added.
| Class | HbA1c drop | Weight | Hypoglycaemia | Other effect |
|---|---|---|---|---|
| Metformin | 1.0 to 1.5 % | Neutral or slight loss | No | The backbone. Cheap, long track record |
|
GLP-1 agonists injectable |
1.0 to 1.8 % | Substantial loss | No | Cardiovascular and kidney benefit. The strongest option |
| SGLT2 inhibitors | 0.5 to 1.0 % | Modest loss | No | Heart failure and kidney protection, independent of glucose |
| Sulfonylureas | 1.0 to 1.5 % | Gain | Yes, significant | Strong and cheap, effect fades over years |
| DPP-4 inhibitors | 0.5 to 0.8 % | Neutral | No | Very well tolerated, no organ benefit |
| Pioglitazone | 0.5 to 1.4 % | Gain, plus fluid | No | Durable effect; fluid retention and fracture risk |
| Meglitinides | 0.5 to 1.5 % | Gain | Yes | Taken with meals, useful for irregular eating |
| Acarbose | 0.5 to 0.8 % | Neutral | No | Targets post-meal spikes; flatulence limits use |
❤️ The change that reorganised the whole subject
Until recently the second drug was chosen by how far the HbA1c was from target. That is no longer how it works, and it is the single most important thing to take from this page.
💡 If you have heart failure, established cardiovascular disease or chronic kidney disease, the second drug is chosen for the organ, not for the sugar — and it is added regardless of whether the HbA1c is at target, because the benefit is separate from glucose lowering.
Someone with heart failure and an HbA1c of 6.8 percent still benefits from an SGLT2 inhibitor. Ten years ago nobody would have added a drug to that person.
| Situation | Preferred addition |
|---|---|
| Heart failure, either type | SGLT2 inhibitor — reduces hospitalisation and death. The strongest indication in the whole field |
| Chronic kidney disease, or protein in the urine | SGLT2 inhibitor, slowing the decline in kidney function. A GLP-1 agonist where an SGLT2 is unsuitable |
| Established cardiovascular disease — previous heart attack, stroke, angina, stents | GLP-1 agonist or SGLT2 inhibitor, both with proven event reduction |
| Obesity as the dominant problem | GLP-1 agonist, far ahead of everything else, then an SGLT2 |
| Cost is the limiting factor | Sulfonylurea or pioglitazone — effective and inexpensive, with the trade-offs in the table above |
| Hypoglycaemia must be avoided — older, frail, driving for a living, living alone | DPP-4 inhibitor or SGLT2 inhibitor. Not a sulfonylurea |
| Irregular meals or shift work | Meglitinide taken with meals and skipped when a meal is skipped |
🧱 Metformin: the dosing and the three rules
Glucophage (Metformin) stays in the regimen when other drugs are added, because it reduces the baseline glucose load that everything else has to work against.
- 🔹 Start 500 mg once or twice daily with food, increasing by 500 mg at weekly intervals to a usual 1000 mg twice daily, maximum around 2000 to 2550 mg daily
- 🍽️ Always with or straight after food. The nausea, cramping and diarrhoea that make people stop are largely an empty-stomach phenomenon, and the extended-release form once daily with the evening meal solves most of the rest
- 📈 Slow titration is the whole trick. Going to full dose in three days produces a week of diarrhoea and a patient who will not try it again
⚠️ Three things about metformin that get missed.
1. Kidneys. The dose is reviewed and usually reduced when eGFR falls below 45, and metformin is stopped below 30. This is not caution for its own sake — accumulation causes lactic acidosis, which is rare and serious.
2. Vitamin B12. Long-term metformin causes B12 deficiency in a meaningful proportion of users, and the resulting nerve symptoms get attributed to diabetic neuropathy and left untreated. B12 is worth checking periodically, certainly if there is any tingling or numbness, and correcting it is simple.
3. Hold it when ill. Stop during vomiting, diarrhoea or any illness causing dehydration, and before contrast imaging or surgery. Restart when eating and drinking normally again.
💧 SGLT2 inhibitors, and the emergency that hides behind a normal glucose reading
These make the kidneys excrete glucose into the urine. The glucose effect is modest; the heart and kidney effect is the reason they are used. Dapavel (Dapagliflozin) is 10 mg once daily, any time, with or without food. Canagliflozin is 100 mg daily, up to 300 mg.
The single-tablet option combining both mechanisms is Oxramet XR (Dapagliflozin with Metformin), and there is a triple preparation adding sitagliptin, Oxramet-S XR, for people already established on all three.
🚨 Diabetic ketoacidosis with a normal or only slightly raised glucose.
SGLT2 inhibitors can cause ketoacidosis while the blood glucose reading looks acceptable, which removes the warning sign people rely on. Nausea, vomiting, abdominal pain, deep or rapid breathing, unusual tiredness or a sweet or fruity smell on the breath means stopping the drug and seeking emergency assessment — and saying explicitly that you take an SGLT2 inhibitor, because a normal glucose can otherwise point the assessment in the wrong direction.
It is provoked by acute illness, fasting, surgery, very low carbohydrate diets, heavy alcohol and missed insulin. The drug is stopped around three days before planned surgery and during any significant illness.
Also: genital and urinary fungal infections are common and treatable, and good hygiene with adequate fluids reduces them. Rarely, severe pain, redness and swelling of the perineum with fever indicates a destructive soft tissue infection and is a surgical emergency. And because these drugs act as a mild diuretic, dizziness on standing is common in the first weeks, particularly alongside a water tablet.
🔵 The gentler additions
- 💊 Januvia (Sitagliptin) — 100 mg once daily. Reduced to 50 mg when eGFR is 30 to 45 and 25 mg below 30. Almost no side effects, no weight gain, no hypoglycaemia, and no organ benefit. Its role is the person who needs a modest improvement with nothing going wrong
- 🟠 Amaryl (Glimepiride) — 1 to 2 mg once daily with breakfast, rarely above 4 mg. Glipizide is 5 mg daily rising to 20 mg in divided doses. Strong, cheap, and the only class on this page that causes hypoglycaemia. Dose down with age and reduced kidney function, never skip a meal after taking it, and be careful with alcohol and unplanned exercise. Anyone who drives needs to know their local rules on glucose testing before driving
- 🟡 Actos (Pioglitazone) — 15 to 30 mg daily, maximum 45 mg. Durable effect and improves fatty liver. Contraindicated in heart failure because of fluid retention, increases fracture risk, and carries a bladder cancer signal, so it is avoided with a history of bladder cancer or unexplained blood in the urine
- 🟢 Precose (Acarbose) — 25 mg three times daily with the first bite, up to 100 mg three times daily. Blocks carbohydrate absorption and targets post-meal spikes specifically. Flatulence and bloating limit how many people stay on it. One practical point: if hypoglycaemia occurs on acarbose plus a sulfonylurea, it must be treated with glucose rather than ordinary sugar, since acarbose blocks the breakdown of sucrose
The full range is in the diabetes category.
💉 A note on GLP-1 agonists
These are the most effective addition available, both for HbA1c and for weight, with proven cardiovascular and kidney benefit. They are injections rather than tablets — mostly weekly — which means cold chain handling and a prescription from a clinician who will teach the technique, and they are not supplied here.
It is worth knowing what to expect if one is started elsewhere: nausea is near-universal at first and managed by slow dose escalation and smaller meals, there is a gallbladder and pancreatitis caution, and anaesthetists now need to be told about them before any procedure because they slow stomach emptying and raise the risk of aspiration under sedation.
🚫 What must not be combined
- ❌ A DPP-4 inhibitor with a GLP-1 agonist. Both act on the same incretin pathway. Adding one to the other produces no additional benefit and doubles the cost — when a GLP-1 is started, the DPP-4 is stopped
- ❌ A sulfonylurea with a meglitinide. Same mechanism, additive hypoglycaemia risk, no extra effect
- ❌ Two drugs from any one class, including two SGLT2 inhibitors under different brand names — worth checking when a fixed-dose combination is involved, since it is easy to take the same ingredient twice without noticing
- ⚠️ A sulfonylurea with insulin needs deliberate dose reduction of one or both; together they are the commonest cause of severe hypoglycaemia
- ⚠️ Pioglitazone with insulin raises the risk of fluid overload and heart failure
🌡️ Sick day rules, which almost nobody is given
This is the most practically useful section here. When you are vomiting, have diarrhoea, cannot keep fluids down, or are dehydrated for any reason, several medicines become harmful rather than helpful because the kidneys are temporarily under-perfused.
| Hold during dehydrating illness | Why |
|---|---|
| Metformin | Risk of lactic acidosis |
| SGLT2 inhibitors | Ketoacidosis and further fluid loss |
| Sulfonylureas | Hypoglycaemia when not eating |
| Water tablets (diuretics) | Worsen the dehydration |
| Blood pressure tablets ending in pril or sartan | Reduce kidney perfusion further |
| Anti-inflammatory painkillers | Same, and they compound the others |
Restart them once eating and drinking normally for a day or so. The same list applies before contrast imaging and before surgery, with the SGLT2 inhibitor stopped around three days beforehand. If you are on several of these, ask for the instruction in writing while you are well, because it is not a decision to work out at three in the morning.
👁️ The checks that prevent the complications
Glucose control is one axis. Most of the damage that actually disables people is prevented by things on this list, and the gaps in it are where diabetes care usually fails.
- 🩸 HbA1c every three to six months while treatment is changing, then twice yearly
- 👁️ Retinal photography every year. Diabetic eye disease is silent until it is advanced, and treatable before that
- 🦶 Feet examined every year, more often with any numbness or deformity. Loss of sensation plus a small injury is how amputations begin
- 🧪 Urine albumin-to-creatinine ratio and eGFR every year. Protein in the urine appears long before kidney function falls and changes the drug choice
- 🩺 Blood pressure at every visit — controlling it prevents more complications in diabetes than tightening glucose does
- 📉 Lipids, and a statin for most people with diabetes over 40 regardless of the cholesterol number
- 💉 Influenza, pneumococcal and COVID vaccination
- 🦷 Dental review, since gum disease and glucose control worsen each other
On lifestyle, two specifics rather than generalities: a brief walk after meals lowers the post-meal glucose rise measurably, more than the same walk at another time of day; and resistance training improves insulin sensitivity independently of weight loss. Weight reduction of 10 to 15 percent can put early type 2 diabetes into remission, which is a genuine possibility within the first few years rather than a slogan.
📞 When to seek help
Emergency:
- Nausea, vomiting, abdominal pain or deep rapid breathing on an SGLT2 inhibitor — even with a normal glucose reading. Say which drug you take
- Severe pain, redness or swelling of the perineum or genitals with fever
- Confusion, drowsiness or inability to swallow with low glucose — needs help from someone else immediately
- Glucose above 20 mmol/L, or 360 mg/dL, with vomiting
- Chest pain, or sudden weakness or speech difficulty
Promptly:
- Repeated hypoglycaemia, or any episode needing help from another person — the regimen needs changing, not just more snacks
- Tingling, numbness or burning in the feet — ask for B12 to be checked as well as a neuropathy assessment
- Any foot ulcer, blister, cut or colour change — same week, not next appointment
- Blurred or changing vision
- Heart failure, kidney disease or previous cardiovascular events and no SGLT2 inhibitor or GLP-1 agonist in the regimen — ask why
- HbA1c above target for six months with no change to the plan
- No sick-day instructions — ask for them in writing
- No retinal screening, foot check or urine albumin test in the past year
❓ Frequently asked questions
Why do I need a second diabetes tablet?
Because the illness has three defects running at once and a single drug addresses one or two of them. Most people treated with one drug need a second within a few years. It reflects the course of the condition rather than anything done wrong.
How is the second drug chosen?
By heart and kidney risk first, not by the HbA1c. Heart failure or kidney disease means an SGLT2 inhibitor, established cardiovascular disease means an SGLT2 or GLP-1, and obesity means a GLP-1 — added even when the HbA1c is already at target.
How much does each drug lower HbA1c?
Roughly: GLP-1 agonists 1.0 to 1.8 percent, metformin and sulfonylureas 1.0 to 1.5, pioglitazone 0.5 to 1.4, SGLT2 inhibitors 0.5 to 1.0, DPP-4 inhibitors and acarbose 0.5 to 0.8.
What is the metformin dose and why does it upset my stomach?
500 mg once or twice daily with food, increasing by 500 mg weekly to about 1000 mg twice daily. The nausea and diarrhoea are largely an empty-stomach effect, so always take it with food, titrate slowly, and ask about the extended-release form.
Can metformin cause vitamin B12 deficiency?
Yes, in a meaningful proportion of long-term users, and the resulting tingling or numbness is often blamed on diabetic neuropathy and left untreated. B12 is worth checking periodically and particularly if nerve symptoms appear.
What are the sick day rules?
During vomiting, diarrhoea or dehydration, hold metformin, SGLT2 inhibitors, sulfonylureas, water tablets, blood pressure tablets ending in pril or sartan, and anti-inflammatory painkillers. Restart once eating and drinking normally.
Can I get ketoacidosis with a normal blood sugar?
Yes, on an SGLT2 inhibitor. Nausea, vomiting, abdominal pain or deep rapid breathing needs emergency assessment even with an acceptable glucose reading, and you should state that you take an SGLT2 inhibitor.
Which combinations should not be used together?
A DPP-4 inhibitor with a GLP-1 agonist, since both act on the same pathway; a sulfonylurea with a meglitinide; and two drugs from any one class, which is easy to do accidentally with fixed-dose combination tablets.
Are combination tablets better than separate ones?
Not pharmacologically, and often in practice, because fewer tablets improves adherence and adherence is what determines the result. The drawback is that doses cannot be adjusted independently, so they suit people already stable on both components.
Can type 2 diabetes be put into remission?
Yes in a proportion of people, particularly within the first few years of diagnosis, with weight reduction of around 10 to 15 percent. Remission means normal glucose without medication and it still requires continued monitoring.
📑 Sources and editorial
- American Diabetes Association standards of care and EASD consensus guidance on glycaemic management in type 2 diabetes, including organ-based selection of the second agent
- Cardiovascular and renal outcome trials of SGLT2 inhibitors and GLP-1 receptor agonists, and the resulting licensed indications in heart failure and chronic kidney disease
- Guidance on individualising HbA1c targets by age, comorbidity and hypoglycaemia risk
- Prescribing information for metformin, dapagliflozin, canagliflozin, sitagliptin, glimepiride, glipizide, pioglitazone, repaglinide, nateglinide and acarbose, including renal dose adjustment
- Regulatory safety communications on euglycaemic diabetic ketoacidosis with SGLT2 inhibitors, on necrotising fasciitis of the perineum, and on perioperative withholding periods
- Reviews of metformin-associated vitamin B12 deficiency and of metformin use by eGFR category
- Guidance on medication adjustment during intercurrent illness and before contrast imaging or surgery
- Anaesthetic society guidance on GLP-1 receptor agonists and delayed gastric emptying before procedures
- Trials of dietary weight management and remission in early type 2 diabetes, and of post-meal walking and resistance training on glycaemic measures
- Screening guidance for diabetic retinopathy, foot disease and diabetic kidney disease
- Related reading: monotherapy in type 2 diabetes
- Related products: Oxramet XR, Glucophage (Metformin), Dapavel (Dapagliflozin), Januvia (Sitagliptin), Amaryl (Glimepiride), diabetes category
- RXshop Editorial Team — reviewed by Daniel Kim, MD — Endocrinologist & Diabetes Specialist
Medical Disclaimer: The information in this article is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek guidance from a qualified healthcare provider with any questions you may have regarding a medical condition, and before starting, stopping or changing any medication.